Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications
Fiammetta Cosci, Guy Chouinard
Psychotherapy and Psychosomatics (2020) Vol. 89, Iss. 5, pp. 283-306
Open Access | Times Cited: 200

Showing 1-25 of 200 citing articles:

Benzodiazepines Remain Important Therapeutic Options in Psychiatric Practice
Steven Dubovsky, Dori Marshall
Psychotherapy and Psychosomatics (2022) Vol. 91, Iss. 5, pp. 307-334
Closed Access | Times Cited: 93
Zuranolone for the Treatment of Adults With Major Depressive Disorder: A Randomized, Placebo‐Controlled Phase 3 Trial
Anita H. Clayton, Robert Lasser, Sagar V. Parikh, et al.
American Journal of Psychiatry (2023) Vol. 180, Iss. 9, pp. 676-684
Closed Access | Times Cited: 51
Depression and Anxiety Disorders
Oğuz Karamustafalıoğlu, Hüseyin Yumrukçal
(2025), pp. 335-476
Closed Access | Times Cited: 7
GABAkines – Advances in the discovery, development, and commercialization of positive allosteric modulators of GABAA receptors
Rok Cerne, Arnold S. Lippa, Michael M. Poe, et al.
Pharmacology & Therapeutics (2021) Vol. 234, pp. 108035-108035
Open Access | Times Cited: 71
Cognitive Behavioral Therapy to Sustain the Antidepressant Effects of Ketamine in Treatment-Resistant Depression: A Randomized Clinical Trial
Samuel T. Wilkinson, Taeho Greg Rhee, Jutta Joormann, et al.
Psychotherapy and Psychosomatics (2021) Vol. 90, Iss. 5, pp. 318-327
Closed Access | Times Cited: 65
What I have learnt from helping thousands of people taper off antidepressants and other psychotropic medications
Adele Framer
Therapeutic Advances in Psychopharmacology (2021) Vol. 11
Open Access | Times Cited: 55
Distinguishing relapse from antidepressant withdrawal: clinical practice and antidepressant discontinuation studies
Mark Horowitz, David Taylor
BJPsych Advances (2022) Vol. 28, Iss. 5, pp. 297-311
Open Access | Times Cited: 40
Long-term use of benzodiazepines in chronic insomnia: a European perspective
Michael Soyka, Imane Wild, Bérangère Caulet, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 32
Effects of different doses of esketamine intervention on postpartum depressive symptoms in cesarean section women: A randomized, double-blind, controlled clinical study
Si Qi Yang, Ying Zhou, Shu Yang, et al.
Journal of Affective Disorders (2023) Vol. 339, pp. 333-341
Closed Access | Times Cited: 30
A case report of exacerbation of extrapyramidal symptoms following the switch from risperidone to paliperidone during valproate therapy
Emi Hata, Masatoshi Miyauchi, Nobuhiko Noguchi, et al.
BMC Psychiatry (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
The ‘patient voice’: patients who experience antidepressant withdrawal symptoms are often dismissed, or misdiagnosed with relapse, or a new medical condition
Anne Guy, Marion Brown, Stevie Lewis, et al.
Therapeutic Advances in Psychopharmacology (2020) Vol. 10
Open Access | Times Cited: 59
May antidepressant drugs worsen the conditions they are supposed to treat? The clinical foundations of the oppositional model of tolerance
Giovanni A. Fava
Therapeutic Advances in Psychopharmacology (2020) Vol. 10
Open Access | Times Cited: 58
Prodromal Symptoms in Depression: A Systematic Review
Giada Benasi, Giovanni A. Fava, Jenny Guidi
Psychotherapy and Psychosomatics (2021) Vol. 90, Iss. 6, pp. 365-372
Closed Access | Times Cited: 54
The role of Facebook groups in the management and raising of awareness of antidepressant withdrawal: is social media filling the void left by health services?
Edward White, John Read, Sherry Julo
Therapeutic Advances in Psychopharmacology (2021) Vol. 11, pp. 204512532098117-204512532098117
Open Access | Times Cited: 53
Continuation of Antidepressants vs Sequential Psychological Interventions to Prevent Relapse in Depression
Josefien Breedvelt, Fiona C Warren, Zindel V. Segal, et al.
JAMA Psychiatry (2021) Vol. 78, Iss. 8, pp. 868-868
Open Access | Times Cited: 48
When Anxiety and Depression Coexist: The Role of Differential Diagnosis Using Clinimetric Criteria
Fiammetta Cosci, Giovanni A. Fava
Psychotherapy and Psychosomatics (2021) Vol. 90, Iss. 5, pp. 308-317
Open Access | Times Cited: 46
Benzodiazepines and Related Sedatives
Linda Peng, Kenneth L. Morford, Ximena A. Levander
Medical Clinics of North America (2021) Vol. 106, Iss. 1, pp. 113-129
Closed Access | Times Cited: 45
Persistent impact of amitriptyline on the behavior, brain neurotransmitter, and transcriptional profile of zebrafish (Danio rerio)
Xuchun Qiu, Chen Chen, Yanhong Shi, et al.
Aquatic Toxicology (2022) Vol. 245, pp. 106129-106129
Open Access | Times Cited: 33
Withdrawal Syndrome Following Discontinuation of 28 Antidepressants: Pharmacovigilance Analysis of 31,688 Reports from the WHO Spontaneous Reporting Database
Chiara Gastaldon, Georgios Schoretsanitis, Elena Arzenton, et al.
Drug Safety (2022) Vol. 45, Iss. 12, pp. 1539-1549
Open Access | Times Cited: 32
Second to none: rationale, timing, and clinical management of clozapine use in schizophrenia
Mishal Qubad, Robert A. Bittner
Therapeutic Advances in Psychopharmacology (2023) Vol. 13
Open Access | Times Cited: 17
Discontinuation of psychotropic medication: a synthesis of evidence across medication classes
Christiaan H. Vinkers, Ralph Kupka, Brenda W.J.H. Penninx, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 8, pp. 2575-2586
Open Access | Times Cited: 7
Gradually tapering off antipsychotics: lessons for practice from case studies and neurobiological principles
Mark Horowitz, Joanna Moncrieff
Current Opinion in Psychiatry (2024) Vol. 37, Iss. 4, pp. 320-330
Open Access | Times Cited: 7
Protracted withdrawal syndrome after stopping antidepressants: a descriptive quantitative analysis of consumer narratives from a large internet forum
Michael P. Hengartner, Lukas Schulthess, Anders Sørensen, et al.
Therapeutic Advances in Psychopharmacology (2020) Vol. 10
Open Access | Times Cited: 46
The Deceptive Manifestations of Treatment Resistance in Depression: A New Look at the Problem
Giovanni A. Fava, Fiammetta Cosci, Jenny Guidi, et al.
Psychotherapy and Psychosomatics (2020) Vol. 89, Iss. 5, pp. 265-273
Open Access | Times Cited: 40
Clozapine discontinuation withdrawal symptoms in schizophrenia
Graham Blackman, Ebenezer Oloyede
Therapeutic Advances in Psychopharmacology (2021) Vol. 11
Open Access | Times Cited: 34
Page 1 - Next Page

Scroll to top